Imagion Biosystems Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IBXXF research report →
About the company
Imagion Biosystems Limited is dedicated to advancing medical imaging through innovative technologies centered on superparamagnetic relaxometry. The company's core mission is to enable the early detection of diseases, with a particular focus on cancer, and to monitor the efficacy of therapeutic interventions. Its operational scope encompasses nanotechnology, biotechnology, and cancer diagnostics, all built upon its proprietary superparamagnetic relaxometry platform.
- CEO
- Robert Romeo Proulx
- IPO
- 2020
- Employees
- 11
- HQ
- San Diego, CA, US
Price Chart
- Market Cap
- $6.63M
- P/E
- -0.71
- P/S
- 94.42
- P/B
- -1.85
- EV/EBITDA
- -0.89
- Div Yield
- 0.00%
- Gross Margin
- -2293.56%
- Op Margin
- -16189.90%
- Net Margin
- -16746.15%
- ROE
- 142.99%
- ROIC
- -1025.50%
- Revenue
- $0 · -100.00%
- Net Income
- $-4,307,762 · -108.41%
- EPS
- $-0.02 · 66.30%
- Op Income
- $-3,583,483
- FCF YoY
- -218.12%
- 52W High
- $0.04
- 52W Low
- $0.01
- 50D MA
- $0.02
- 200D MA
- $0.01
- Beta
- -0.21
- Avg Volume
- 2.99K
Get TickerSpark's AI analysis on IBXXF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our IBXXF coverage
Recent articles, reports, and earnings notes.
No research on IBXXF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IBXXF report →Similar companies
Peers in the same neighborhood.